First global technological standard for engineered bacteria being released in Zhangjiang

2023 June 15, in the 25th Shanghai International Forum on Biotechnology & Pharmaceutical Industry, the first global technological standard for engineered bacteria was released. CommBio made significant contribution to the drafting of the standard

CommBio's CSO Dr. Peter Atadja presents at the 25th Shanghai International Forum on Biotechnology & Pharmaceutical Industry

2023 June 15, CommBio's CSO Dr. Peter Atadja presents at the 25th Shanghai International Forum on Biotechnology & Pharmaceutical Industry. His talk, titled “Combining Synthetic Biology and Bacteria Gene Delivery Approaches to Target Intestinal Biology for Metabolic and Chronic Disease Therapy”, highlights advances of CommBio Therapeutics and in the industry.

CommBio named “top 10 biotech with most growth potential”

2023 June 13, the “2023 China Biomedical Innovation Value List” award ceremony took place in Shanghai. CommBio was named in the Top 10 Biotech with Most Growth Potential list.

CommBio CEO Dr. Bin Xiang interviewed by Shanghai Techology

2023 May 11, CommBio's CEO Dr. Bin Xiang tells the story of CommBio – an innovation-driven biotech startup he founded after leaving MNC pharmaceutical company, and how CommBio collaborated with the Shanghai Center of Biomedicine Development.

CommBio's VP of genetic engineering Dr. Li Zhu presents at the Engineering Biology Innovation Forum IV / SynBio China II

2023 April 27, CommBio's vice president of genetic engineering Dr. Li Zhu presents at the Engineering Biology Innovation Forum IV / SynBio China II / Asian Synthetic Biology Innovation Forum I in Shenzhen, Guangdong.